Allen & Overy has strengthened its international IP practice in China with the addition of partner David Shen, who has been general counsel at biopharmaceutical drug giant AstraZeneca since 2011.

A lawyer with a Ph.D in Chemistry, Shen is expected to lead the firm’s China IP and life sciences division. He has a wide experience in patents and patent litigation, and his expertise covers the life sciences sector with respect to regulatory and compliance.

He has also worked for Eli Lilly, Bayer Corporation and Knoble & Yoshida.

In December, A&O appointed PE and funds specialist Wayne Lee as a partner in Shanghai from Shearman & Sterling.

Related Articles

Appointments

史密夫斐尔联营所科伟迎知识产权专家加盟（ZH/EN）

by Hu Yangxiaoxiao 胡阳潇潇 |

与史密夫斐尔律师事务所联营的科伟律师事务所迎来知识产权专家雷鹏律师以合伙人身份加盟。加入科伟前，雷律师在汉坤律师事务所任合伙人。

Appointments

A&O bolsters IP practice with China hire

by Raj Gunashekar |

Allen & Overy has strengthened its international IP practice in China with the addition of partner David Shen, who has been general counsel at biopharmaceutical drug giant AstraZeneca since 2011.

Appointments

Sheppard Mullin Beijing duo joins Perkins Coie

by Ines Yang |

Perkins Coie has two partners in Beijing from Sheppard Mullin, namely hired Jim M.Zimmerman, who led the office at his previous firm, and Scott J.Palmer.